Endo 2
Growth Hormone Function and Etiology of Imbalance
Physiological Role of Growth Hormone (GH):
Synthesized and secreted by the anterior pituitary gland.
Essential for promoting structural growth in cartilage and soft tissue throughout development.
Regulates metabolic processes beyond structural growth into adulthood, specifically affecting blood glucose homeostasis. Dysregulation can precipitate diabetes mellitus and severe glycemic instability.
Serum GH abnormalities serve as primary indicators of pituitary gland or hypothalamic dysfunction.
Etiology of GH Deficiency:
Malnutrition is the single most common cause worldwide.
Pituitary or hypothalamic tumors.
Surgical removal of pituitary tissue.
Hereditary/genetic defects.
Physical trauma.
Psychosocial neglect or severe emotional stress.
Pediatric GH Deficiency (Pituitary Dwarfism):
Height restriction typically limits growth to .
Anatomical body proportions remain completely normal and symmetrical; stature is short, but head, trunk, and limb ratios are preserved.
Delayed or slowed sexual maturation due to concurrent impairment of other anterior pituitary tropic hormones.
Potential development of intellectual disability / mental retardation.
Adult GH Deficiency:
Fatigue and generalized muscular weakness.
Increased central and systemic adiposity paired with reduced lean muscle mass and decreased bone mineral density.
Sexual dysfunction.
Altered lipid metabolism leading to hypercholesterolemia (elevated low-density lipoproteins [LDLs], total cholesterol, and triglycerides).
Marked increase in risk for coronary artery disease (CAD), myocardial infarction (MI) secondary to coronary arterial occlusion by atheromatous plaques, cardiovascular collapse, and cerebrovascular accidents (strokes).
Chronic headaches, cognitive slowness, psychological disturbances, and reduced overall quality of life.
Diagnostic Protocols for GH Deficiency:
Standard routine blood tests are unreliable because normal GH secretion occurs in unpredictable pulsatile bursts, causing extreme physiological serum fluctuations.
Growth hormone stimulation testing is required to confirm diagnostic deficiency.
Magnetic Resonance Imaging (MRI) is utilized to visualize the sella turcica and screen for pituitary or hypothalamic tumors.
Genetic testing to identify hereditary etiologies.
Therapeutic and Nursing Interventions for GH Deficiency:
Administration of exogenous recombinant GH produced via recombinant DNA technology, which provides a safer and more accessible supply.
Surgical resection is indicated if pituitary or hypothalamic tumors are the underlying cause.
Comprehensive assessment of patient baseline mental status, coping mechanisms, and comprehension of complex lifelong treatment regimens.
Monitoring cardiovascular health and serial lipid panels (measuring LDLs, HDLs, total cholesterol, and triglycerides).
Maintaining a respectful, non-judgmental approach; acknowledging that patients with childhood-onset deficiency have adapted to chronic physical limitations over time.
Gigantism and Acromegaly
Definitions and Age of Onset:
Gigantism: Pathological GH hypersecretion originating during childhood prior to the closure of epiphyseal growth plates.
Acromegaly: Pathological GH hypersecretion developing in adulthood, most commonly diagnosed between the ages of .
Etiology:
Benign pituitary adenomas leading to pituitary tissue hyperplasia.
Hypothalamic dysfunction resulting in excessive secretion of Growth Hormone-Releasing Hormone (GHRH).
Pathophysiology and Structural Manifestations:
Epiphyseal plates in long bones (such as the femur) fuse after puberty, making vertical growth impossible in adults.
Excess GH forces adult long bones to grow thicker and wider rather than longer.
Marked enlargement of soft tissue across facial and distal extremities, including the nose, jaw (prominent prognathism), brow ridge (frontal bossing), hands, and feet.
Visceromegaly (enlargement of internal organs and glands), leading to chronic body pain.
Rapid increases in shoe and ring sizes, increased subcutaneous tissue deposition, dental displacement, malocclusion, difficulty chewing, and ill-fitting dentures.
Advanced physical changes: tongue thickening (macroglossia) causing impaired speech (dysarthria) and swallowing difficulties (dysphagia), obstructive sleep apnea, visual field disturbances due to optic chiasm compression, persistent headaches, and impaired carbohydrate tolerance causing elevated blood glucose levels and secondary diabetes mellitus.
Structural osseous (bone) changes are permanent and non-reversible. Therapeutic intervention can only reduce excess soft tissue and subcutaneous fat hypertrophy.
Diagnostic and Medical Management:
Direct measurement of serum GH levels.
Diagnostic neuroimaging (CT or MRI scans) to identify pituitary tumor presence and size.
Pharmacotherapy using GH-receptor antagonists or somatostatin analogs to inhibit GH synthesis/action.
Hypophysectomy (surgical excision of the pituitary gland).
Radiation therapy utilized independently or as an adjunct when surgical tumor resection is contraindicated or incomplete.
Complete surgical removal of the pituitary gland mandates permanent, lifelong replacement of all essential pituitary hormones.
Pituitary Tumors and Hypophysectomy
Pathophysiology of Pituitary Adenomas:
Overwhelmingly benign in nature.
Clinical manifestations stem from local mass effect: compression of the optic nerve/chiasm causes visual disturbances; expansion within the bony sella turcica elevates intracranial pressure (ICP); and neoplastic tissue alters systemic hormone secretion.
Surgical Approaches for Hypophysectomy:
Endoscopic Transsphenoidal Approach: Minimally invasive approach performed through the nasal cavity or via a small incision under the upper lip (sublabial incision).
Transfrontal Craniotomy: Invasive open procedure requiring entry through the frontal bone of the skull, reserved for large tumors extending beyond the sella turcica.
Pre-Operative Nursing Protocols:
Verify and confirm signed informed consent forms.
Confirm patient understanding of the precise surgical entry route (transnasal, sublabial, or transfrontal craniotomy).
Perform and document a meticulous baseline neurological assessment (level of consciousness, orientation, cranial nerves) to evaluate post-operative changes (e.g., comparing baseline alert and oriented status against post-operative confusion).
Educate the patient regarding post-operative expectations, monitoring, and strict physical restrictions.
Post-Operative Nursing Management and Complications:
Perform frequent neurological evaluations and compare findings continuously against pre-operative baseline data.
Assess urine output and measure urine specific gravity to detect Diabetes Insipidus (DI), an acute post-operative complication caused by Antidiuretic Hormone (ADH) deficiency (characterized by massive polyuria, dilute urine, and extreme thirst).
Inspect nasal packing and sublabial mustache dressings. The primary healthcare provider/surgeon performs the initial post-operative dressing change.
Monitor for Cerebrospinal Fluid (CSF) leaks: collect and inspect clear nasal or oral drainage. Test clear drainage with bedside glucose test strips (CSF contains high glucose concentrations) or assess for the "halo sign" (a central ring of blood surrounded by a clear ring of fluid on gauze dressings). Notify the provider immediately if CSF leakage is suspected.
Enforce strict precautions to prevent spikes in Intracranial Pressure (ICP) and stress on the surgical incision site: instruct the patient to strictly avoid coughing, sneezing, bending over at the waist, or straining during bowel movements.
Perform deep breathing exercises and use an incentive spirometer for pulmonary hygiene; coughing is strictly contraindicated. Administer prescribed antitussives (cough suppressants/cough drops) as needed.
Administer routine stool softeners to prevent straining during defecation.
Oral hygiene care for transsphenoidal sublabial incisions: avoid toothbrushing with hard-bristled toothbrushes to prevent suture disruption; utilize soft foam sponge swabs and soft food diets until complete healing occurs.
Standard hospital length of stay is approximately . Provide explicit discharge instructions regarding expected minor blood-tinged discharge versus overt surgical hemorrhage.
Educate on the strict requirement for lifelong hormone replacement therapy, including synthetic thyroid hormones, glucocorticoids, intranasal desmopressin (DDAVP), and sex hormones.
Hypothyroidism and Myxedema Coma
Overview and Classifications:
Characterized by deficient production and secretion of thyroid hormones ( and ).
Most frequently diagnosed in women over of age. Congenital hypothyroidism causes developmental impairment in infants, making routine neonatal lab screening standard.
Primary Hypothyroidism: Functional failure of the thyroid gland itself. Etiologies include congenital aplasia, thyroiditis, severe dietary iodine deficiency, and Hashimoto's thyroiditis (an autoimmune condition where autoantibodies attack and destroy thyroid glandular tissue).
Secondary Hypothyroidism: Inadequate secretion of Thyroid-Stimulating Hormone (TSH) from the anterior pituitary gland.
Tertiary Hypothyroidism: Inadequate secretion of Thyrotropin-Releasing Hormone (TRH) from the hypothalamus.
Hypothalamic-Pituitary-Thyroid (HPT) Axis: The hypothalamus secretes TRH stimulates the anterior pituitary to secrete TSH stimulates the thyroid gland to synthesize and release and .
Clinical Manifestations of Hypothyroidism:
Systemic metabolic deceleration: weight gain despite reduced appetite, severe fatigue, lethargy, and mental slowness/dullness.
Cardiovascular: bradycardia, reduced cardiac output, dyspnea, and hyperlipidemia (elevated total cholesterol and triglycerides due to diminished lipid clearance), escalating the risk for heart failure.
Gastrointestinal: decreased intestinal motility resulting in chronic severe constipation.
Integumentary: extreme cold intolerance, diminished diaphoresis (sweating), and dry, rough skin.
Myxedema and Myxedema Coma:
Myxedema: Advanced, long-standing untreated hypothyroidism presenting with non-pitting mucinous edema around the face, hands, and feet.
Myxedema Coma: A life-threatening, acute medical emergency precipitated by severe physiological stress (such as systemic infections, cold exposure, trauma, or surgery) in patients with uncontrolled hypothyroidism.
Clinical features: severe hypothermia, hypoventilation/respiratory depression, profound lethargy, depressed sensorium, severe hypoglycemia, hypotension, reduced renal perfusion, acute heart failure, and death.
Emergency interventions: endotracheal intubation and mechanical ventilation (as patients lose the ability to maintain spontaneous respiration), slow and controlled passive rewarming, intravenous fluid resuscitation, high-dose intravenous synthetic thyroid hormone (Levothyroxine / Synthroid), and immediate identification/treatment of the underlying precipitating cause.
Immediate notification of the registered nurse (RN) or healthcare provider is mandatory upon detecting acute alterations in vital signs or mental status.
Diagnostic Protocols:
Serum and levels (characteristically low).
Serum TSH testing: markedly elevated in primary hypothyroidism (due to the intact pituitary trying to stimulate the failing thyroid gland); abnormally low in secondary hypothyroidism.
Lipid profile evaluation (serum cholesterol and triglycerides) and blood glucose testing.
Serum autoantibody titers to confirm Hashimoto's thyroiditis.
Pharmacotherapy and Patient Teaching:
Administration of oral synthetic thyroid hormone replacement: Levothyroxine (Synthroid).
Treatment is initiated at low dosages and titrated upward gradually to avoid precipitating acute hyperthyroidism, angina, or cardiac overloading.
Instruct patients on the absolute necessity of consistent, lifelong daily medication adherence and routine laboratory monitoring (, , and TSH levels).
Instruct patients to report signs of hyperthyroidism immediately to their provider.
Advise patients to exercise caution when driving or operating heavy machinery during initial medication initiation due to potential neuro-metabolic shifts.
Hyperthyroidism and Thyroid Storm
Overview and Etiology:
Pathological hypersecretion of thyroid hormones ( and ), most commonly diagnosed in females.
Primary hyperthyroidism stems from thyroid overactivity (e.g., Graves' disease, toxic multinodular goiter/nodules, thyroiditis, or thyroid neoplasm).
Secondary hyperthyroidism stems from TSH-secreting pituitary tumors; tertiary stems from hypothalamic hypersecretion of TRH.
Exogenous hyperthyroidism can be caused by excessive administration of synthetic thyroid hormone medication.
Graves' Disease: An autoimmune disorder where thyroid-stimulating immunoglobulins constantly trigger excess thyroid hormone release. Cigarette smoking significantly increases the risk of Graves' disease in women. Genetic factors contribute to autoimmune thyroid diseases.
Clinical Manifestations of Hyperthyroidism:
Systemic hypermetabolic state: pronounced heat intolerance, profuse diaphoresis, hyperphagia (increased appetite) accompanied by continuous weight loss, and hypermotility of the GI tract causing hyperdefecation/diarrhea.
Neuromuscular and Cardiac: fine muscle tremors, extreme nervousness, restlessness, persistent tachycardia, and palpitations secondary to excessive epinephrine release (simulating a constant sympathetic fight-or-flight state). Uncontrolled tachycardia leads directly to high-output heart failure.
Psychiatric manifestations: manic episodes or overt psychosis. Mandatory clinical practice requires checking serum thyroid hormone levels in psychiatric admissions to rule out underlying endocrine hyperfunction before initiating antipsychotics.
Graves'-Specific Signs: pretibial myxedema (indurated, thickened skin over the anterior lower legs), exophthalmos (proptosis/bulging eyes), photophobia, blurred vision, and diplopia (double vision).
Atypical Presentation in Older Adults: Older patients may present without classic hypermetabolic signs, showing "apathetic hyperthyroidism" manifested by new-onset Atrial Fibrillation (A-fib), acute heart failure, severe fatigue, acne, and depression.
Thyroid Storm (Thyrotoxic Crisis):
An acute, life-threatening exacerbation of hyperthyroidism triggered by physiological stress, illness, infection, or performing thyroid surgery on a patient who has not been adequately prepared with antithyroid medications.
Clinical features: extreme tachycardia, hyperpyrexia (high fever), severe hypertension progressing to heart failure, profound dehydration, extreme agitation/restlessness, delirium, and coma.
Emergency Management Priorities:
Priority 1: Immediate reduction of life-threatening cardiovascular symptoms using intravenous Beta-blockers (e.g., Propranolol) to control tachycardia and hypertension.
Fever Management: Administer Acetaminophen (Tylenol). Aspirin is strictly contraindicated because aspirin competes with for thyroxine-binding globulin sites, displacing bound into free serum and escalating the thyrotoxic state.
Hemodynamic support: IV fluid resuscitation for dehydration, gradual external cooling using cooling blankets, supplemental oxygen, and elevating the head of the bed.
Definitive antithyroid pharmacotherapy once stable.
Pharmacotherapy and Non-Surgical Management:
Antithyroid Thionamides: Methimazole (inhibits thyroid hormone synthesis; requires of continuous therapy to achieve therapeutic effectiveness) or Propylthiouracil (PTU).
Beta-blockers to manage hyperadrenergic symptoms (tachycardia, hypertension, tremors).
Supplemental Calcium and Vitamin D to protect bone density during hypermetabolic states.
Radioactive Iodine (): Ablative therapy administered as a single oral dose to destroy hyperactive thyroid parenchymal cells.
Thyroidectomy and Post-Operative Management
Indication and Pre-Operative Care:
Performed via open surgical resection or minimally invasive techniques when medical management fails or large goiters/tumors are present.
Administer antithyroid medications (Methimazole or PTU) pre-operatively to suppress thyroid function, achieving a euthyroid state prior to surgery to reduce the risk of triggering post-operative thyroid storm.
Administer oral iodine preparations (such as Lugol's solution or saturated solution of potassium iodide [SSKI]) pre-operatively to reduce thyroid gland vascularity and minimize surgical hemorrhage.
Obtain baseline vital signs and perform a formal pre-operative voice quality assessment (evaluating for baseline hoarseness due to the proximity of the recurrent laryngeal nerve).
Instruct the patient on gentle neck support techniques, neck exercises, and the pre- and post-operative use of an incentive spirometer.
Post-Operative Nursing Protocols and Complications:
Monitor vital signs continuously for signs of surgical shock or impending thyrotoxic crisis (fever, tachycardia, altered mental status).
Hemorrhage Check: inspect the anterior surgical dressing and routinely slide hands behind the patient's neck to check for hidden blood pooling in posterior tissues.
Airway Assessment: monitor for acute respiratory distress, dyspnea, and laryngeal stridor caused by soft tissue edema compressing the trachea.
Maintain an Emergency Tracheostomy Kit directly at the patient's bedside at all times.
Evaluate voice quality post-operatively for hoarseness or vocal weakness, which indicates intraoperative damage to the recurrent laryngeal nerve.
Assess serum calcium levels and monitor for acute hypocalcemia and tetany caused by accidental devascularization or excision of the parathyroid glands.
Post-Thyroidectomy Care Mnemonic ("BOW TIE"):
B: Bleeding (assess anterior dressing and posterior neck pooling).
O: Open airway (assess for stridor, dyspnea, and tracheal compression).
W: Whisper test (evaluate voice quality for recurrent laryngeal nerve damage).
T: Tracheostomy kit at bedside.
I: Incision evaluation (monitor for bleeding and signs of infection).
E: Emergency response readiness.
Tetany and Radioactive Iodine Therapy Precautions
Tetany (Post-Thyroidectomy Hypocalcemia):
Pathophysiology: The four parathyroid glands located on the posterior surface of the thyroid secrete Parathyroid Hormone (PTH), which mobilizes calcium from bone into the bloodstream. Inadvertent surgical removal or trauma during thyroidectomy causes acute PTH drop and severe hypocalcemia.
Clinical features: perioral paresthesia (tingling around the mouth), paresthesia in fingers and toes, muscle twitching, painful muscle spasms, cardiac dysrhythmias on ECG monitoring, and life-threatening laryngospasm causing complete airway closure.
Emergency Treatment: Immediate, slow intravenous infusion of Calcium Gluconate. Promptly report all signs of paresthesia or twitching following thyroid surgery.
Radioactive Iodine () Safety Precautions:
Administered as a single oral dose. High doses require inpatient isolation; low doses are managed in outpatient settings.
Inpatient / High-Dose Radiation Safety:
Limit direct nursing bedside exposure time and maintain maximal physical distance.
Pregnant healthcare personnel must completely avoid all contact with the patient.
Dispose of radioactively contaminated body fluids per hospital nuclear safety protocols; double-flush toilets after every use.
Outpatient / Low-Dose Home Safety:
Avoid close physical proximity with other individuals.
Enforce rigorous hand hygiene.
Avoid any oral contact: wash eating utensils thoroughly and separately between uses; do not share food, drink, or utensils.
Strictly avoid pregnancy for following therapy.
Expected side effects: radiation thyroiditis/sore throat, dry mouth (xerostomia), dry eyes, and nausea.
Clinical improvement of hyperthyroid symptoms typically occurs over .
Instruct patients to maintain high fluid intake and void frequently to accelerate urinary excretion of radioactive iodine and minimize radiation exposure to the urinary bladder wall.